Michael M. Abecassis serves as Executive at PharmaCyte Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Michael M. Abecassis has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 12, 2025 involved selling 16,875 shares valued at $17.2K.
Michael M. Abecassis currently holds 22,292 shares of PharmaCyte Biotech, Inc. (PMCB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael M. Abecassis has been a net neutral trader of PMCB stock. They have purchased $0 and sold $0 worth of shares.
Michael M. Abecassis's most recent insider trade was on Dec 12, 2025, when they sold 16,875 shares at $1.02 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |